Oncopharmpod
Lurbinectedin et al
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:18:12
- Mas informaciones
Informações:
Sinopsis
Topics on this week's Pod include: -Lurbinectedin in SCLC -Nivolumab is esophageal cancer -Pembrolizumab for TMB-high cancers -Gemtuzumab ozogamicin for pediatric AML -Venetoclax + HMA for adult (unfit) AML -Gardasil for prevention of SCCHN -Perhaps the biggest non-oncopharm news of the year?
